IRIS
FRUMENTO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 141
Totale 141
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 141
Totale 141
Salva come PNG Salva come JPEG
Città #
Genova 79
Genoa 36
Rapallo 23
Bordighera 3
Totale 141
Salva come PNG Salva come JPEG
Nome #
A2A-D2 heteromers on striatal astrocytes: Biochemical and biophysical evidence, file e268c4ca-16dc-a6b7-e053-3a05fe0adea1 108
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives., file e268c4ce-4158-a6b7-e053-3a05fe0adea1 9
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress, file 723e031a-e913-4838-92b7-0cc56fecdc2e 7
Acute stress induces short- and long-lasting modifications of glutamate transmission in the prefrontal cortex at pre- and peri-synaptic compartments, file e268c4ce-8509-a6b7-e053-3a05fe0adea1 6
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation, file 86fe5d1d-64df-4c7f-aab4-a875866edb07 3
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity, file 52f25230-2c8c-4add-9613-fa057ab63037 2
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis, file 653999f3-655a-4cb0-a1c9-a901a105df8f 2
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity, file 6f5a9781-8886-40e6-91a1-d9a02fa0d402 2
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex., file 0c4d4b92-a6f1-45ee-9918-88d092bb5381 1
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS, file e268c4ce-5f16-a6b7-e053-3a05fe0adea1 1
Totale 141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 425
article - articoli 387
book - libri 0
conference - conferenze 12
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 6 5 5 2 2
2020/202137 1 2 1 2 2 0 1 2 0 21 3 2
2021/202224 2 0 6 0 2 2 1 0 1 1 6 3
2022/202328 1 0 4 6 1 5 4 1 1 0 5 0
2023/202432 0 1 3 1 3 3 15 4 2 0 0 0
Totale 141